Alendronate sodium and Multiple sclerosis - a phase IV clinical study of FDA data
Summary:
Multiple sclerosis is reported as a side effect among people who take Alendronate sodium (alendronate sodium), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Fosamax, and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people have Multiple sclerosis when taking Alendronate sodium. It is created by eHealthMe based on reports of 42,896 people who have side effects when taking Alendronate sodium from the FDA, and is updated regularly.
What is Alendronate sodium?
Alendronate sodium has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 43,608 Alendronate sodium users. Check the latest studies of Alendronate sodium.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,085 drugs and 1,365 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
42,896 people reported to have side effects when taking Alendronate sodium.
Among them, 99 people (0.23%) have Multiple sclerosis.

Among these 99 people:
How long have people been on Alendronate sodium when they have Multiple sclerosis? *
- < 1 month: 0.0 %
- 1 - 6 months: 50 %
- 6 - 12 months: 10 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 30 %
- 5 - 10 years: 10 %
- 10+ years: 0.0 %
What is the gender of people who have Multiple sclerosis when taking Alendronate sodium? *
- female: 95.88 %
- male: 4.12 %
What is the age of people who have Multiple sclerosis when taking Alendronate sodium? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 6.35 %
- 40-49: 12.7 %
- 50-59: 22.22 %
- 60+: 58.73 %
What are other drugs people take besides Alendronate sodium? *
- Fosamax: 27 people, 27.27%
- Ampyra: 21 people, 21.21%
- Tecfidera: 19 people, 19.19%
- Vitamin D3: 16 people, 16.16%
- Avonex: 15 people, 15.15%
- Prednisone: 12 people, 12.12%
- Gabapentin: 10 people, 10.10%
- Enbrel: 10 people, 10.10%
- Vitamin D: 9 people, 9.09%
- Vumerity: 8 people, 8.08%
What are other side effects people have besides Multiple sclerosis? *
- Fall: 34 people, 34.34%
- Gait Disturbance: 24 people, 24.24%
- Joint Pain: 21 people, 21.21%
- Drug Ineffective: 20 people, 20.20%
- Urinary Tract Infection: 19 people, 19.19%
- Back Pain: 19 people, 19.19%
- Femur Fracture: 19 people, 19.19%
- Stress And Anxiety: 19 people, 19.19%
- Weakness: 18 people, 18.18%
- High Blood Pressure: 18 people, 18.18%
What are the existing conditions these people have? *
- Gait Disturbance: 11 people, 11.11%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 11.11%
- High Blood Pressure: 8 people, 8.08%
- High Blood Cholesterol: 6 people, 6.06%
- Depression: 6 people, 6.06%
- Diarrhea: 5 people, 5.05%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 4.04%
- Balance Disorder: 4 people, 4.04%
- Hypersensitivity: 4 people, 4.04%
- Insomnia (sleeplessness): 4 people, 4.04%
* Approximation only. Some reports may have incomplete information.
Do you take Alendronate sodium and have Multiple sclerosis?
- Check whether Multiple sclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Alendronate sodium:
- Alendronate sodium (43,608 reports)
Multiple sclerosis treatments and more:
- Multiple sclerosis (799,637 reports)
How severe was Multiple sclerosis and when was it recovered:
Expand to all the drugs that have ingredients of alendronate sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Alendronate sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Multiple sclerosis:
- Multiple sclerosis (1,085 drugs)
Browse all the conditions that are associated with Multiple sclerosis:
- Multiple sclerosis (1,365 conditions)
Related publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on alendronate sodium (the active ingredients of Alendronate sodium) and Alendronate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Exposed Bone In Jaw and drugs of ingredients of ergocalciferol - a second ago
- Remicade and Colitis Ischaemic for Women aged 60+ - 3 seconds ago
- Could Humira cause Lymph Node Tuberculosis? - 6 seconds ago
- Could Acetaminophen cause Postoperative Ileus? - 16 seconds ago
- Feldene and Pain - Muscles for Women aged 60+ - 17 seconds ago
- Feldene and Myalgia for Women aged 60+ - 18 seconds ago
- Feldene and Muscle Pain for Women aged 60+ - 18 seconds ago
- Feldene and Muscle Aches for Women aged 60+ - 18 seconds ago
- Interstitial Lung Disease and Aseptic Necrosis - 22 seconds ago
- Could Flonase cause Injection Site Urticaria? - 23 seconds ago